Table 1 Univariate analysis of 106 patients with Carbapenem-Resistant-Klebsiella pneumonia bacteremia who received the ceftazidime-avibactam (CAZ-AVI) within 7 days of positive blood culture.

From: Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions

 

Survived

n = 71 (67%)

Fatal

n = 35 (33%)

p

Male gender

44 (62)

21 (60)

0.845

Mean Age

51 (sd: 17)

59 (sd: 18)

0.033

Mean Pitt bacteremia score

4.1 (sd: 3.2)

7 (sd: 2.6)

< 0.001

Charlson Comorbidity index

5.2 (sd: 11.6)

4.3 (sd: 2.7)

0.648

Severe neutropenia

12 (17)

9 (26)

0.284

Malignancy

27 (38)

14 (40)

0.845

Mean initiation time of CAZ-AVI after blood culture collection (days)

2.1 (sd: 1.9)

2.9 (sd: 1.85)

0.035

Patients initiated with CAZ-AVI on the day of blood culture was obtained

23 (32.3)

3 (8.5)

0.007